Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Revenue

Adaptive Biotechnologies had revenue of $70.87M in the quarter ending March 31, 2026, with 35.14% growth. This brings the company's revenue in the last twelve months to $295.41M, up 55.87% year-over-year. In the year 2025, Adaptive Biotechnologies had annual revenue of $276.98M with 54.77% growth.

• Revenue (ttm): $295.41M
• Revenue Growth: +55.87%
• P/S Ratio: 7.48
• Revenue / Employee: $473,409
• Employees: 624
• Market Cap: 2.24B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	276.98M	98.02M	54.77%
Dec 31, 2024	178.96M	8.68M	5.10%
Dec 31, 2023	170.28M	-15.03M	-8.11%
Dec 31, 2022	185.31M	30.96M	20.06%
Dec 31, 2021	154.34M	55.96M	56.88%
Dec 31, 2020	98.38M	13.31M	15.65%
Dec 31, 2019	85.07M	29.41M	52.83%
Dec 31, 2018	55.66M	17.22M	44.77%
Dec 31, 2017	38.45M	-	-

Data Source: Fiscal.ai Last updated: May 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 22, 2026

Data Sources Report a data error